Should we start being genetically tested for Parkinson’s disease (PD)? According to research just published in the December issue of the "journal Movement Disorders" this might be a possibility in the future if you belong to a family affected by G2019S, a genetic mutation responsible for some PD cases.
Parkinson disease results from the death or loss of function of the nervous cells (neurons) in a brain area called substancia nigra, which is involved in the regulation of movement. Neurons within this region produce dopamine, a neurotransmitter that acts as messenger between the substancia nigra (the control centre) and other neurons around the body, leading to a correct regulation of the body movements. If the substancia nigra degenerates, like it happens in PD, dopamine is no longer properly produced and the individual starts presenting the typical symptoms of Parkinson’s disease such as slowed movements, tremors, loss of movement control and rigidity.
Although there is still no cure, treatments, which increase the brain’s dopamine levels, are relatively effective. Unfortunately, as disease progresses, treatment becomes less and less efficient and the patient’s full deterioration is inevitable. The disease affects about 1% of the world population with, only in the US, half a million people affected and about 50,000 new cases are reported every year, a number predicted to increase as the average age of the populations also increases.
Catarina Amorim | alfa
What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
06.12.2016 | Health and Medicine
06.12.2016 | Life Sciences
05.12.2016 | Power and Electrical Engineering